Research programme: anticoagulants - LigaChem
Alternative Names: I FVIIa - LigaChem Biosciences; I Fxa - LigaChem; I FXIa - LigaChemLatest Information Update: 08 Jan 2025
At a glance
- Originator LegoChem Biosciences
- Developer LigaChem Biosciences
- Class Small molecules
- Mechanism of Action Factor VIIa modulators; Factor XI modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Blood coagulation disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Coagulation-disorders in South Korea (IV)
- 16 Jul 2016 No recent reports of development identified for research development in Coagulation-disorders in South Korea (PO)